Cytokine regulation of epithelial permeability and ion transport

Gut

Volumn 44, Issue 2, 1999, Pages 283-289

  McKay, D M ^a   Baird, A W ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; CELL MEMBRANE PERMEABILITY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033061476     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.2.283     Document Type: Review

References (114)

1. Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 1994;72:135-41.
2. Radford-Smith G, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 1996;10:151-64.
3. Brynskov J, Nielsen OH, Ahnfelt-Ronne I, et al. Cytokines in inflammatory bowel disease. Scand J Gastroenterol 1992;27:897-906.
4. Remick DG Kunkel SL. Pathophysiologic alterations induced by tumor necrosis factor. Int Rev Exp Pathol 1993;34:7-25.
5. Garside P, Bunce C, Tomlinson RC, et al. Analysis of enteropathy induced by tumour necrosis factor alpha. Cytokine 1993;5:24-30.
6. Arend WP. Inhibiting the effects of cytokines in human diseases. Adv Intern Med 1995;40:365-94.
7. Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994;267:G151-65.
8. Unno N, Menconi MJ, Smith M, et al. Nitric oxide mediates interferon-gamma induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 1995;23:1170-6.
9. Di Paolo MC, Merrett MN, Crotty B, et al. 5-aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. Gut 1996;38:115-19.
10. Gustafson-Svard C, Tagesson C, Boll R, et al. Tumour necrosis factor α potentiates phospholipase A2 release and arachidonic acid metabolism in cultured intestinal epithelial cell (INT 407). Scand J Gastroenterol 1993;28: 323-30.
11. McKay DM, Philpott DJ, Perdue MH. In vitro models in inflammatory bowel disease research - a critical review. Aliment Pharmacol Ther 1997;11(suppl 3):70-80.
12. Castro GA, Arntzen CJ. Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system. Am J Physiol 1993;265:G599.
13. Brandtzaeg P, Halstensen TS, Kett K, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97:1562.
14. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1997;100:6-10.
15. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997;18:428-32.
16. Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997;85:16-20.
17. Sheth R, Anderson J, Sato T, et al. Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 1996;221:251-9.
18. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immunol 1993;61:4569-74.
19. Pender SLF, Tickle SP, Docherty AJP, et al. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90.
20. Meddings JB. Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther 1997;11(suppl 3):47-56.
21. Welsh FKS, Farmery SM, MacLennan K, et al. Gut barrier function in malnourished patients. Gut 1998;42:396-401.
22. Fink MP. Effect of critical illness in microbial translocation and gastrointestinal mucosa permeability. Semin Respir Infect 1994;9:256-60.
23. Lewis SA, Berg JR, Kleine TJ. Modulation of epithelial permeability by extracellular macromolecules. Physiol Rev 1995;75:561-89.
24. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
25. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial cells. Biochem Biophys Acta 1991;175:880-5.
26. Balda MS, Whitney JA, Flores C, et al. Functional disassociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane difusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 1996; 134:1031-49.
27. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 1995;269:G467-75.
28. Madara JL, Parkos CA, Colgan SP, et al. The movement of solutes and cells across tight junctions. Ann NY Acad Sci 1992;664:47-60.
29. Madara JL, Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-7.
30. Planchon SM, Martins CAP, Guerrant RL, et al. Regulation of intestinal barrier function by TGF-β1. J Immunol 1994;153:5730-9.
31. Matthews JB, Smith JA, Hrnjez BJ. Effects of F-actin stabilization or disassembly on epithelial Cl secretion and Na-K-2Cl cotransport. Am J Physiol 1997;272:C254-62.
32. Zund G, Madara JL, Dzus A, et al. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J Biol Chem 1996;271:7460-4.
33. Hilton DJ, Zhang J-G, Metcalf D, et al. Cloning and characterisation of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Nat Acad Sci USA 1996;93:497-501.
34. Targan SR, Hanauer SB, van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med 1997;337:1029-35.
35. Stack WA, Mann SD, Roy AJ, et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease. Lancet 1997;349: 521-4.
36. Mullin JM, Laughlin KV, Marano CW, et al. Modulation of tumour necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. Am J Physiol 1992;263:F915-24.
37. Mullin JM, Smock KV. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 1990;50:2172-6.
38. Zareie M, McKay DM, Kovarik G, et al. Monocyte/macrophages evoke epithelial dysfunction: indirect role of tumor necrosis factor α. Am J Physiol 1998;275:C932-9.
39. McKay DM, Croitoru K, Perdue MH. T cell monocyte interactions regulate epithelial physiology in a co-culture model of inflammation. Am J Physiol 1996;270:C418-28.
40. Taylor CT, Murphy A, Kelleher D, et al. Changes in barrier function of a model intestinal epithelium by intraepithelial lymphocytes requires new protein synthesis by epithelial cells. Gut 1997;40:634-40.
41. Taylor CT, Dzus AL, Colgan SP. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 1998;114:657-68.
42. Madsen KL, Lewis SA, Tavernini MM, et al. Interleukin 10 prevents cytokine-induced disruption of T84 monolayers barrier integrity and limits chloride secretion. Gastroenterology 1997;113:151-9.
43. Hiribarren A, Heyman M, L'Helgouac'h A, et al. Effect of cytokines on the epithelial function of a human carcinoma cell line HT29 cl 19A. Gut 1993; 34:616-20.
44. Tsujimoto M, Yip YK, Vilocek J. Interferon-gamma enhances expression of cellular receptors for tumour necrosis factor. J Immunol 1986;136: 2441-44.
45. McKay DM, Singh PK. Superantigen-activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via interferon-γ and tumour necrosis factor-α. Inhibition of increased permeability, but not diminished secretory responses by transforming growth factor β2. J Immunol 1997;159:2382-90.
46. Lu J, Philpott DJ, Saunders PR, et al. Epithelial transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by IL-10, but not IL-4. J Pharm Exp Ther 1998;287:128-36.
47. Van Deventer SJH, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology 1997; 113:383-9.
48. Ciacci C, Lind SE, Podolsky DK. Transforming growth factor β regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 1993;105:93-101.
49. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 1993;105:1323-32.
50. Nusrat A, Parkos CA, Liang TW, et al. Neutrophil migration across model epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 1997;113:1489-500
51. McRoberts J, Riley N. Regulation of T84 cell monolayer permeability by insulin like growth factors. Am J Physiol 1992;262:C207-13.
52. Uribe JM, Barrett KE. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology 1997;112:255-68.
53. Kaoutzani P, Colgan SP, Cepek KL, et al. Reconstitution of cultured intestinal epithelial monolayers with a mucosal derived T lymphocyte cell line: modulation of epithelial phenotype dependent on lymphocyte basolateral membrane apposition. J Clin Invest 1994;94:788-96.
54. Heyman M, Darmon N, Dupont C, et al. Mononuclear cells form infants allergic to cow's milk secrete tumour necrosis factor α, altering intestinal function. Gastroenterology 1994;106:1514-23.
55. Rodriguez P, Heyman M, Candalh C, et al. Tumour necrosis factor-α induces morphological and functional alterations of intestinal HT29 cl. 19A cell monolayers. Cytokine 1995;7:441-8.
56. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996;270:G225-37.
57. Gaginella T, Kachur J, Tamai H, et al. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology 1995;109: 2019-28.
58. 2a production. J Clin Invest 1997;100:296-309.
59. Kerneis S, Bogdanova A, Kraehenbuhl J-P, et al. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 1997;277:949-52.
60. Neutra MR, Frey A, Kraehenbuhl J-P. Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996;86:345-8.
61. Savidge TC, Smith MW, James PS, et al. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue. Am J Pathol 1991;139:177-84.
62. Borghesi C, Regoli M, Bertelli E, et al. Modifications of the follicle associated epithelium by short term exposure to a non-intestinal bacterium. J Pathol 1996;180:326-32.
63. Galan JE, Bliska JB. Cross talk between bacterial pathogens and their host cells. Ann Rev Cell Dev Biol 1996;12:221-55.
64. Hershberg R, Nepom GT. Regulation of antigen presentation by an intestinal epithelial cell line. J Clin Invest 1997;100:204-15.
65. Mayer L, So LP, Yio XY, et al. Antigen trafficking in the intestine. Ann NY Acad Sci 1996;778:28-35.
66. Neuman B, Luz A, Pfeffer K, et al. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 1996;184:259-64.
67. Mayrhofer G. Peyer's patch organogenesis cytokines rule, OK? Gut 1997; 41:707-9.
68. Pasparakis M, Alexopoulou L, Grell M, et al. Peyer's patch organogenesis is intact, yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and 55-kDa receptor. Proc Natl Acad Sci USA 1997;94:6319-23.
69. Orchard T, Jewell DP. Pathophysiology of intestinal mucosa. Aliment Pharmacol Ther 1997;11(suppl 3):10-6.
70. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
71. Mayer L. Current concepts in mucosal immunity. I. Antigen presentation in the intestine: new rules and regulations. Am J Physiol 1998;274:G7-9.
72. Barrett KE, Dharmsathaphorn K. Secretion and absorption: small intestine and colon. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of gastroenterology. Philadeplhia: JB Lippincott Co., 1991: 265-94.
73. Holmgren J, Frylund J, Larsson H. Gamma-interferon mediated down regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism? Scand J Immunol 1989;30:499-503.
74. Chiossone DC, Simon PL, Smith PL. Interleukin-1: effects on rabbit ileal mucosal ion transport in vitro. Eur J Pharmacol 1990;180:217-28.
75. Chang EB, Musch M, Mayer L. Interleukins 1 and 3 stimulate anion secretion in chicken intestine. Gastroenterology 1990;98:1513-24.
76. Kandil HM, Berschneider HM, Argenzio RA. Tumour necrosis factor α changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 1994;35:934-40.
77. 2. Am J Physiol 1996;271:G667-74.
78. Berschneider HM, Powell DW. Fibroblasts modulate intestinal secretory responses to inflammatory mediators. J Clin Invest 1992;89:484-9.
79. + transport by an L-arg dependent mechanism. Am J Physiol 1994;266:C1330-41.
80. Ciacci C, Mahida Y, Dignass A, et al. Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest 1993;92:527-32.
81. Madsen KL, Tavernini MM, Mosmann TR, et al. Interleukin 10 modulates ion transport in rat small intestine. Gastroenterology 1996;111:936-44.
82. Shapiro M, Matthews J, Hecht G, et al. Stabilization of F-actin prevents cAMP-elicited Cl secretion in T84 cells. J Clin Invest 1991;87:1903-9.
83. +/2Cl co-transport by cAMP in intestinal epithelial monolayers. J Clin Invest 1992;90:1608-13.
84. Opleta-Madsen K, Hardin J, Gall DG. Epidermal growth factor upregulates intestinal electrolyte and nutrient transport. Am J Physiol 1991;260:G807-14.
85. 2+ dependent Cl transport in T84 human colonic epithelial cells. Am J Physiol 1996;271:C914-22.
86. Uribe JM, Keely SJ, Traynor-Kaplan AE, et al. Phosphatitidyl-inositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion. J Biol Chem 1996;271:26588-95.
87. Borok Z, Hami A, Danto S, et al. Effects of EGF on alveolar epithelial junctional permeability and active sodium transport. Am J Physiol 1996;270: L559-65.
88. Hecht G, Pestic L, Nikcevic G, et al. Expression of the catalytic domain of myosin light chain kinase increases paracellular permeability. Am J Physiol 1996;271:C1678-84.
89. Shanahan F. Designer drugs for inflammatory bowel diseases. Gastroenterology 1997;112:2153-8.
90. Neurath MF, Pettersson S, Meyer zum Buschenfelde KHM, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 1996;2:998-1004.
91. Keates S, Hitti YS, Upton M, et al. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 1997;113:1099-109.
92. Jobin C, Haskill S, Mayer L, et al. Evidence for altered regulation of IκB degradation in human colonic epithelial cells. J Immunol 1997;158:226-34.
93. Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996;84:331-4.
94. Reinecker H, MacDermott RP, Mirau S, et al. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996;111:1706-13.
95. Warhurst AC, Hopkins SJ, Warhurst G. Intereferon γ induces differential upregulation of α and β chemokine secretion in colonic epithelial cell lines. Gut 1998;42:208-213.
96. Grimm MC, Elsbury SKO, Pavli P, et al. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 1996;38:90-8
97. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
98. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
99. Sartor RB. The role of enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 1997;11(suppl 3):17-23.
100. Sears C, Kaper J. Enteríc bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev 1996;60:167-215.
101. Yamada T, Sartor RB, Marshall S, et al. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 1993; 104:759-71.
102. Rook GAW, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-16.
103. Strober W, Kelsall B. To be responsive or not to be responsive, that is the mucosal question. Gastroenterology 1998;114:214-17.
104. Eldridge JH, Staas JK, Chen D, et al. New advances in vaccine delivery systems. Semin Hematol 1993;30:16-25.
105. Powell MF. Drug delivery issues in vaccine development. Pharmacol Res 1996;13:1777-85.
106. Trinchieri G. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4006-27.
107. Marinaro M, Boyaka PN, Finkelman FD, et al. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 1997;185:415-27.
108. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112:1169-78.
109. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-55.
110. Bramson JL, Graham FL, Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotech 1995;6:590-5.
111. Jobin C, Panja A, Hellerbrand C, et al. Inhibition of proinflammatory molecule production by adenovirus mediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells. J Immunol 1998;160: 410-18.
112. Hyde SC, Gill DR, Higgins G, et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993;362: 250-4.
113. Brown GR, Thiele DL, Silva M, et al. Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium. Gastroenterology 1997;112:1586-94.
114. Croyle MA, Walter E, Janich S, et al. Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum Gene Ther 1998;9:561-73.